Literature DB >> 11802952

[Association between asthma and the polymorphism of HLA-DQ genes].

X Guo1, P Ni, L Li.   

Abstract

OBJECTIVE: To investigate association between asthma and HLA-DQ genes in Chinese asthma family.
METHODS: HLA genotyping was done for HLA-DQ using polymerase chain reaction-sequence specific primers (PCR-SSP) in 98 members of 32 Chinese asthma families and 67 normal controls.
RESULTS: The allele frequencies of DQA1 * 0101 and DQA1 * 0601 in asthmatics (40.0% and 45.0% respectively) were significantly higher than those in normal controls (16.4% and 13.4% respectively; chi(2) = 6.1860, P < 0.05, RR = 3.39 and chi(2) = 11.609 0, P < 0.01, RR = 5.27 respectively). The allele frequencies of DQB1 * 0303 and DQB1 * 0601 in asthmatics (55.0% and 47.5% respectively) were also significantly higher than those in normal controls (13.7% and 13.7% respectively; chi(2) = 15.740 0, P < 0.01, RR = 7.68 and chi(2) = 10.930 0, P < 0.01, RR = 5.69 respectively). The allele frequency of DQ * 0201 (39.4%) was significantly higher in members with positive specific IgE response to dermatophagoides than that in non-atopy members (12.0%) in asthma family (t = 2.382 5, P < 0.05).
CONCLUSION: HLA-DQA1* 0101, DQA1 * 0601 and HLA-DQB1 * 0303, DQB1 * 0601 may be the susceptible alleles of asthma. HLA-DQB1 * 0201 allele may limit the specific IgE response to dermatophagoides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11802952

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  2 in total

1.  An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations.

Authors:  Tieying Hou; Henriette Macmillan; Zhenjun Chen; Catherine L Keech; Xi Jin; John Sidney; Michael Strohman; Taejin Yoon; Elizabeth D Mellins
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

2.  HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults.

Authors:  J Lasky-Su; B E Himes; B A Raby; B J Klanderman; J Senter Sylvia; C Lange; E Melen; F D Martinez; E Israel; J Gauderman; F Gilliland; P Sleiman; H Hakonarson; J C Celedón; M Soto-Quiros; L Avila; J J Lima; C G Irvin; S P Peters; H Boushey; V M Chinchilli; D Mauger; K Tantisira; S T Weiss
Journal:  Clin Exp Allergy       Date:  2012-12       Impact factor: 5.018

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.